1. Home
  2. INAB vs EFOI Comparison

INAB vs EFOI Comparison

Compare INAB & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • EFOI
  • Stock Information
  • Founded
  • INAB 2016
  • EFOI 1985
  • Country
  • INAB United States
  • EFOI United States
  • Employees
  • INAB N/A
  • EFOI N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • EFOI Building Products
  • Sector
  • INAB Health Care
  • EFOI Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • EFOI Nasdaq
  • Market Cap
  • INAB 14.5M
  • EFOI 12.1M
  • IPO Year
  • INAB 2021
  • EFOI 1994
  • Fundamental
  • Price
  • INAB $2.49
  • EFOI $2.40
  • Analyst Decision
  • INAB Strong Buy
  • EFOI
  • Analyst Count
  • INAB 2
  • EFOI 0
  • Target Price
  • INAB $108.00
  • EFOI N/A
  • AVG Volume (30 Days)
  • INAB 185.2K
  • EFOI 21.9K
  • Earning Date
  • INAB 08-07-2025
  • EFOI 08-12-2025
  • Dividend Yield
  • INAB N/A
  • EFOI N/A
  • EPS Growth
  • INAB N/A
  • EFOI N/A
  • EPS
  • INAB N/A
  • EFOI N/A
  • Revenue
  • INAB N/A
  • EFOI $4,643,000.00
  • Revenue This Year
  • INAB N/A
  • EFOI N/A
  • Revenue Next Year
  • INAB N/A
  • EFOI N/A
  • P/E Ratio
  • INAB N/A
  • EFOI N/A
  • Revenue Growth
  • INAB N/A
  • EFOI N/A
  • 52 Week Low
  • INAB $2.05
  • EFOI $1.14
  • 52 Week High
  • INAB $27.30
  • EFOI $2.95
  • Technical
  • Relative Strength Index (RSI)
  • INAB 44.14
  • EFOI 63.02
  • Support Level
  • INAB $2.10
  • EFOI $2.23
  • Resistance Level
  • INAB $2.30
  • EFOI $2.42
  • Average True Range (ATR)
  • INAB 0.13
  • EFOI 0.22
  • MACD
  • INAB 0.10
  • EFOI 0.03
  • Stochastic Oscillator
  • INAB 96.70
  • EFOI 90.48

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About EFOI Energy Focus Inc.

Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.

Share on Social Networks: